Trial DSMM XV

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

DSMM XV

Full title

Pomalidomide, ixazomib, and dexamethasone (PId) with or without intensification by cyclophosphamide (PICd): A phase II study in relapsed or refractory multiple myeloma

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Indications

Classification	Code	Description
-		Bloodcancer (leukemia, lymphoma)

Trial design

Phase

Status

Recruitment finished

Votes

Institutional review board - vote

Positive

Institutional review board - vote date

2016-11-17

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Chemo

Participants

	Function	Prename	Surname	Organization
	Responsible contact	Florian	Bassermann	3. Med 3. Med Ismaninger Str. 22 81675 München Germany